Clinical Trial Update: Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study assessing how multiple dosing of BI 201335 influences the pharmacokinetics of darunavir when co-administered with ritonavir in healthy volunteer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• BI 201335
• Darunavir (darunavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2015-07-31